Treatment decisions become clearer when benefit, risk, burden, and goals are discussed separately. This guide prepares that conversation; it does not direct anyone to alter or stop treatment without the prescribing clinician.
Return to the original reason
Write down the original diagnosis and cause statement, the target symptom or function, a baseline example of its severity, what change would count as meaningful, a current example (better, unchanged, worse, or unclear), and other treatments or life changes that may explain it. A laboratory value does not replace the clinical outcome that justified the exposure.
Reasons staying may make sense
- Diagnosis: still credible.
- Benefit: the target symptom improved meaningfully.
- Exposure: appropriate and interpretable for the formulation.
- Safety: findings acceptable to the treating clinician.
- Fertility: goals compatible with the plan.
- Sustainability: administration, monitoring, cost, and access.
- Stability: no new disease or medicine has changed the balance.
Reasons a change may make sense
A change should solve a named problem, not stand in for escalation. A new formulation brings new instructions, exposure pattern, and monitoring.
- Transfer risk or household exposure problem
- Adverse effect: skin, nasal, injection, or procedural
- Routine: difficulty following the schedule
- Measurement: uninterpretable peaks, troughs, or laboratory timing
- Access: cost, insurance, pharmacy, travel, or supply problem
- Inadequate benefit despite appropriate exposure and a credible diagnosis
- Safety signal that may be formulation related
Record the problem the change solves, the new burden it creates, and how and when it will be judged.
Every standard formulation suppresses fertility, and each brings its own burdens: gel carries transfer risk, injections bring needles and peaks and troughs, pellets cannot be adjusted once placed, nasal is short-acting but not fertility-safe without semen measurement, and compounded products are not equivalent to approved ones. The current label governs use.
Reasons a pause or stop may make sense
- No meaningful benefit despite an adequate supervised trial
- Weak diagnosis: incomplete or no longer credible
- Safety: a finding or new contraindication changes the balance
- Fertility has become a priority
- Burden: treatment, cost, or monitoring exceeds its value
- Preference: I no longer want treatment
- Goals of care changed by frailty, serious illness, or another life event
Record the reason, the risks of continuing, the expected symptoms of stopping, specialist input needed, and the clinician's supervised plan. Product clearance, symptom change, hormone recovery, and sperm recovery follow different courses; understand that before a stop date is set.
Do not wait for the routine date
Emergency symptoms need emergency care, not a message for a future visit.
- Chest pressure, stroke symptoms, fainting, or severe shortness of breath
- Sudden severe scrotal pain, a testicular mass, or genital injury
- Severe headache with visual change or another neurologic concern
- Marked blood-pressure change, new swelling, or worsening heart failure
- New severe sleepiness, witnessed breathing pauses, or worsening sleep apnea
- Urinary retention, blood in urine, or a concerning prostate finding
- New clot, arrhythmia, cardiovascular event, hospitalization, or surgery
- New cancer diagnosis, major kidney or liver disease, or serious psychiatric change
- Fertility goal changes or pregnancy becomes time sensitive
- Product, pharmacy, insurance, or supply changes
If the answer remains uncertain
Uncertainty does not require automatic continuation or abrupt discontinuation. A time-limited next step is reasonable when everyone knows what will settle the question and when: the specific uncertainty, the endpoint to observe (symptom, laboratory, semen, safety), the review point, the finding that would favor each choice, and the risk that should end the trial early.
Decision summary
Record the decision today (stay, change, pause, stop, or more evaluation), the main reason, the important uncertainty, the fertility consequence, any safety issue or referral, the next review, and the clinician responsible.
Common questions
How do I know whether I should stay on TRT, switch products, or stop?
Discuss benefit, risk, burden, and goals separately, starting from the original target symptom and a baseline example of its severity. Staying makes sense when the diagnosis remains credible, the symptom improved meaningfully, exposure is interpretable, safety is acceptable, fertility goals fit, and the routine is sustainable. A change should solve a named problem, and a stop is considered when benefit is absent, the diagnosis is weak, safety or fertility changes the balance, or you no longer want treatment.
What symptoms on TRT should not wait for my next scheduled visit?
Emergency symptoms need emergency care: new chest pressure, stroke symptoms, fainting, severe shortness of breath, sudden severe scrotal pain or a testicular mass, severe headache with visual change, marked blood-pressure change or new swelling, worsening sleep apnea, urinary retention or blood in urine, a new clot or cardiovascular event, a new cancer diagnosis, or a serious psychiatric change. Fertility becoming time sensitive and product or supply changes also warrant prompt contact.